Dietary fat composition and dementia risk
- PMID: 24970568
- PMCID: PMC4107296
- DOI: 10.1016/j.neurobiolaging.2014.03.038
Dietary fat composition and dementia risk
Abstract
This is a qualitative review of the evidence linking dietary fat composition to the risk of developing dementia. The review considers laboratory and animal studies that identify underlying mechanisms as well as prospective epidemiologic studies linking biochemical or dietary fatty acids to cognitive decline or incident dementia. Several lines of evidence provide support for the hypothesis that high saturated or trans fatty acids increase the risk of dementia and high polyunsaturated or monounsaturated fatty acids decrease risk. Dietary fat composition is an important factor in blood-brain barrier function and the blood cholesterol profile. Cholesterol and blood-brain barrier function are involved in the neuropathology of Alzheimer's disease, and the primary genetic risk factor for Alzheimer's disease, apolipoprotein E-ε4, is involved in cholesterol transport. The epidemiologic literature is seemingly inconsistent on this topic, but many studies are difficult to interpret because of analytical techniques that ignored negative confounding by other fatty acids, which likely resulted in null findings. The studies that appropriately adjust for confounding by other fats support the dietary fat composition hypothesis.
Keywords: Alzheimer's disease; Cognitive decline; Dementia; Diet; Fatty acids; Monounsaturated fats; Polyunsaturated fats; Saturated fats; Trans fats.
Copyright © 2014 Elsevier Inc. All rights reserved.
Conflict of interest statement
Dr. Morris is a consultant for Abbott Nutrition and Nutrispective, and has received honoraria from the Physicians’ Committee for Responsible Medicine and the National Institute on Aging.
Dr. Tangney has no potential conflicts of interest.
References
-
- American Psychological Association. Diagnostic and Statistical Manual of Mental Disorders: DSM IV-TR. 4. Washington, D.C: 2000.
-
- Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER, 3rd, Conlin PR, Erlinger TP, Rosner BA, Laranjo NM, Charleston J, McCarron P, Bishop LM OmniHeart Collaborative Research Group. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA. 2005;294:2455–2464. - PubMed
-
- Bennett DA, Evans DA. Alzheimer’s disease. Dis Mon. 1992;38:1–64. - PubMed
-
- Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE, Cochran EJ, Berry-Kravis E, Bienias JL. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer’s disease. Neurology. 2003;60:246–252. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
